Alpha Cognition is trading at $7.54 (13.6% down) as investors lock in gains following a sharp multi-session rally fueled by Alzheimer’s program optimism and bullish analyst sentiment.
- The decline appears to be a mix of company-specific profit-taking and broader market pressure rather than any new negative fundamental catalysts.
- The drop is being compounded by a wider biotechnology sector pullback, with the XBI benchmark falling over 3% today.